It has been recently suggested that the risk of graft loss after liver transplantation (LT) may increase in female HCV patients. The aim of the study was to examine gender differences in HCV therapy tolerance and outcome in LT patients treated for HCV recurrence. A retrospective study was conducted on liver recipients with HCV recurrence, who were given antiviral therapy from 2001 to 2009 in 12 transplant centers in Italy. Sustained virological response (SVR), adherence-to-therapy, and side effects were evaluated. A multivariate logistic regression model was used after adjusting for possible confounders. The data regarding 342 treated patients were analyzed. SVR was reported in 38.8% of patients. At baseline, male and female did not differ in HCV viral load, histology, or rate of diabetes. SVR was lower in females than in males (29.5% vs. 42.1%; P=0.03). Adherence-to-therapy was also lower in females than in males 43.4% vs. 23.8%; P=0.001); anemia was the main reason for lower adherence. In a multivariate analysis in patients Genotype1, female gender (P<0.04), early virological response (P<0.0001), and adherence to therapy (P<0.0001) were independent predictors for SVR. In conclusion, female gender represents an independent negative prognostic factor for the outcome of HCV antiviral therapy after LT.
|Data di pubblicazione:||2012|
|Titolo:||Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients.|
|Autori:||Giannelli, V; Giusto, M; Farcomeni, A; Ponziani, Fr; Pompili, M; Viganò, R; Iemmolo, Rm; Donato, Mf; Rendina, M; Toniutto, P; Pasulo, L; Morelli, Mc; De Martin, E; Miglioresi, L; Di Paolo, D; Fagiuoli S, Merli M; Gerunda, Ge; Study, AISF RECOLT-C group .|
|Digital Object Identifier (DOI):||10.1111/j.1432-2277.2012.01440.x|
|Appare nelle tipologie:||Articolo su rivista|
File in questo prodotto:
I documenti presenti in Iris Unimore sono rilasciati con licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 3.0 Italia, salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris